Skip to main content
PMC home page
Acta Veterinaria Scandinavica logoLink to Acta Veterinaria Scandinavica
. 1974 Dec 1;15(4):461–486. doi: 10.1186/BF03547220

Toxicity of Halogenated Oxyquinolines in Dogs. a Clinical Study

V. Pathological Findings

Toxiciteten av halogenerade oxikinoliner hos hund. En klinisk Studie. V. Patolog-anatomiska förändringar

Birgitta Lannek 1,✉, Lennart Jönsson 1
PMCID: PMC8555164  PMID: 4455081

Abstract

A description is given of the post-mortem findings in 21 cases of acute spontaneous oxyquinoline poisoning in dogs after administration of halogenated oxyquinoline drugs once or over a short period. The findings are in accordance with the results of necropsy of 7 cases of experimentally induced oxyquinoline poisoning. Biopsy specimens of the liver were taken in 18 dogs. The investigation reveals that spontaneous as well as experimental poisonings give rise to severe myocardial and liver injuries. The myocardial lesions consisted of focal necrosis with interstitial cellular reaction. The areas of necrosis were most frequent in the papillary muscles of the left ventricle. The liver-cell damage ranged from cloudy swelling to hydropic degeneration with depositions of lipids. In 3 experimental cases, in which rapid fixation methods were used, it was possible to evaluate the pathological lesions in the neurons of the brain and spinal cord. Degenerative neuronal changes with chromatolysis and vacuolation were observed, especially in the hippocampus and hypothalamus. It was presumed that the injuries and destruction of these structures had caused symptoms that were consistent with the clinical pictures of the dogs. The clinical symptoms and post-mortem changes were believed to be due to a toxic effect on the myocardium, liver, and central nervous system.

Keywords: dogs, oxyquinolines, convulsions, liver injury, myocardial injury, neuronal degeneration, hippocampus, hypothalamus

Full Text

The Full Text of this article is available as a PDF (3.7 MB).

Footnotes

Supported by grants from the Swedish Medical Research Council.

References

  1. Annotation: More on S.M.O.N Lancet 1971, 2, 1244.
  2. Bajusz E., Jasmin G. Enzyme histochemistry of some chemically induced cardiac necroses. I. Myocardial lesions induced by plasmocid. II. Vitamin-, Hormon- und Fermentforsch. 1965;14:28–42. [PubMed] [Google Scholar]
  3. Bajusz E., Jasmin G., Mongeau A. Dissociation by forced muscular exercise of the cardiotoxic from the myotoxic actions of plasmocid. Rev. canad. Biol. 1964;23:29–36. [PubMed] [Google Scholar]
  4. Bengtsson K., Vikrot O. Retrograd amnesi efter broxikinolin. (Retrograde amnesia after broxyquinoline). Svenska Läk.-Tidn. 1972;69:14–16. [PubMed] [Google Scholar]
  5. Berggren L., Hansson O. Treating acrodermatitis enteropathica. Lancet. 1966;1:52. doi: 10.1016/S0140-6736(66)90040-7. [DOI] [Google Scholar]
  6. Berggren L., Hansson O., Wahlberg I. Läkemedelsbiverkan och tarm-resorbtion av 8-hydroxikinolinpreparat. (Secondary effect and absorption from the intestine of 8-hydroxyquinoline drugs). Svenska Läk.-Tidn. 1968;65:3772–3773. [Google Scholar]
  7. D’Agostino A. N. An electron microscopic study of skeletal and cardiac muscle of the rat poisoned by plasmocid. Lab. Invest. 1963;12:1060–1071. [PubMed] [Google Scholar]
  8. Drachman D. A., Arbit J. Memory and the hippocampal complex. Arch. Neurol. (Chic.) 1966;15:52–61. doi: 10.1001/archneur.1966.00470130056005. [DOI] [PubMed] [Google Scholar]
  9. Etheridge J. E., Jr., Stewart G. T. Treating acrodermatitis enteropathica. Lancet. 1966;1:261–262. doi: 10.1016/S0140-6736(66)90076-6. [DOI] [Google Scholar]
  10. Griffith, R. W.: Intestopan, a 26-week oral toxicity study in dogs. Sandoz Ltd., Dept. Pharm. Tox., March 28/1969 (unpublished).
  11. Hangartner P. Troubles nerveux observés chez le chien après absorption d’Entéro-Vioforme Giba. (Nervous symptoms observed in dogs after absorption of Enterovioform Ciba). Schweiz. Arch. Tierheilk. 1965;107:43–47. [Google Scholar]
  12. Hoerlein, B. F.: Canine Neurology — Diagnosis and Treatment. 2nd Ed., W. B. Saunders Company, Philadelphia 1971.
  13. Igata A. Comments. Lancet. 1971;2:42–43. [Google Scholar]
  14. Kaeser H. E., Scollo-Lavizzari G. Akute zerebrale Störungen nach hohen Dosen eines Oxychinolinderivates. (Acute cerebral disturbance after high doses of an oxyquinoline derivative). Dtsch. med. Wschr. 1970;95:394–397. doi: 10.1055/s-0028-1108472. [DOI] [PubMed] [Google Scholar]
  15. Kaeser H. E., Wüthrich R. Zur Frage der Neurotoxizität der Oxychinoline. (On the possible neurotoxicity of oxyquinoline). Dtsch. med. Wschr. 1970;95:1685–1688. doi: 10.1055/s-0028-1108711. [DOI] [PubMed] [Google Scholar]
  16. Kjaersgaard K. Amnesia after clioquinol. Lancet. 1971;2:1086. doi: 10.1016/S0140-6736(71)90397-7. [DOI] [PubMed] [Google Scholar]
  17. Lannek B. Leverbiopsi hos hund. Ett diagnostiskt hjälpmedel. (Liver biopsy in dogs. A diagnostic aid). Svensk Vet.-Tidn. 1968;21:591–594. [Google Scholar]
  18. Lannek B. Toxicity of halogenated oxyquinolines in dogs. A clinical study. I. A survey of cases. Acta vet. scand. 1973;14:723–744. doi: 10.1186/BF03547401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lannek B. Toxicity of halogenated oxyquinolines in dogs. A clinical study. II. History, symptoms, laboratory findings, therapy, and follow-up. Acta vet. scand. 1974;15:219–238. [PubMed] [Google Scholar]
  20. Lannek B., Lindberg P. Vioform poisoning in dogs. The absorption of vioform from the intestine. Svensk Vet.-Tidn. 1972;11:438–441. [Google Scholar]
  21. Lannek B., Lindberg P. Toxicity of halogenated oxyquinolines to dogs. The effect of feeding fouled herring. Acta vet. scand. 1972;13:441–442. doi: 10.1186/BF03547059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lannek B., Lindberg P. Toxicity of halogenated oxyquinolines in dogs. A clinical study. III. Intoxication experiments. Acta vet. scand. 1974;15:398–418. doi: 10.1186/BF03547467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lannek B., Lindberg P. Toxicity of halogenated oxyquinolines in dogs. A clinical study. IV. Tissue distribution and elimination in urine. Acta vet. scand. 1974;15:419–435. doi: 10.1186/BF03547468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Marshall P. N., Horobin R. W. The chemical nature of the gallocyanin-chrome alum staining complex. Stain Technol. 1972;47:155–161. doi: 10.3109/10520297209116471. [DOI] [PubMed] [Google Scholar]
  25. Müller L. F. Die Mexaformvergiftung des Hundes (Klinische Demonstration) (The mexaform poisoning in the dog. Clinical demonstration). Kleintier-Prax. 1967;12:51–52. [Google Scholar]
  26. Nakae K., Yamamoto S., Igata A. Subacute myelo-opticoneuropathy (S.M.O.N.) in Japan. Lancet. 1971;2:510–512. doi: 10.1016/S0140-6736(71)90436-3. [DOI] [PubMed] [Google Scholar]
  27. Poley R. W., Fobes L. C. D., Hall M. J. Fuchsinophilia in early myocardial infarction. Arch. Path. 1964;77:325–329. [PubMed] [Google Scholar]
  28. Püschner H., Fankhauser R. Neuropathologische Befunde bei experimenteller Vioform-Vergiftung der weissen Maus. (Neurological symptoms after experimental Vioform poisoning in the white mouse). Schweiz. Arch. Tierheilk. 1969;111:371–379. [PubMed] [Google Scholar]
  29. Redding R. W. Diagnosis and therapy of seizures. J. Animal Hosp. Ass. 1969;5:79–92. [Google Scholar]
  30. Richter R. The effect of certain quinoline compounds upon the nervous system of monkeys. J. Neuropath, exp. Neurol. 1949;8:155–170. doi: 10.1097/00005072-194904000-00003. [DOI] [PubMed] [Google Scholar]
  31. Schantz B., Wikstrom B. Suspected poisoning with oxyquinoline preparations in dogs. Svensk Vet.-Tidn. 1965;4:106–107. [Google Scholar]
  32. Schmidt I. G., Schmidt L. H. Neurotoxicity of the 8-aminoquinolines. II. Reactions of various experimental animals to plasmocid. J. comp. Neurol. 1949;91:337–351. doi: 10.1002/cne.900910303. [DOI] [PubMed] [Google Scholar]
  33. Schmidt I. G., Schmidt L. H. Neurotoxicity of the 8-amino-quinolines. III. The effects of pentaquine, isopentaquine, primaquine and pamaquine on the central nervous system of the rhesus monkey. J. Neuropath, exp. Neurol. 1951;10:231–256. doi: 10.1097/00005072-195107000-00001. [DOI] [PubMed] [Google Scholar]
  34. Schneider H., Coper H. Morphologische Befunde am Zentralnerven-system der Ratte nach Vergiftung mit Antimetaboliten den Nicotinamids (6-aminonicotinsaureamid und 3-acetylpyridin) und einem Chinolinderivat (5-nitro-8-hydroxychinolin) (Morphologic findings in the central nervous system of the rat at poisoning by antimetabolites of the nicotine amids and quinoline derivatives). Arch. Psychiat. Nervenkr. 1968;211:138–154. doi: 10.1007/BF00344410. [DOI] [PubMed] [Google Scholar]
  35. Sobue I., Ando K., Iida M., Takayanagi T., Yamamura Y., Matsuoka Y. Myeloneuropathy with abdominal disorders in Japan. Neurology (Bombay) 1971;21:168–173. doi: 10.1212/WNL.21.2.168. [DOI] [PubMed] [Google Scholar]
  36. Stahl J. Studies on the blood ammonia in liver disease. Ann. intern. Med. 1963;58:1–24. doi: 10.7326/0003-4819-58-1-1. [DOI] [PubMed] [Google Scholar]
  37. Stranduik B., Zetterstrom R. Amaurosis after broxyquinoline. Lancet. 1968;1:922–923. doi: 10.1016/S0140-6736(68)90280-8. [DOI] [PubMed] [Google Scholar]
  38. Tateishi J., Kuroda S., Saito A., Otsuki S. Myelo-optic neuropathy induced by clioquinol in animals. Lancet. 1971;2:1263–1264. doi: 10.1016/S0140-6736(71)90584-8. [DOI] [PubMed] [Google Scholar]
  39. Tsubaki T., Honma Y., Hoshi M. Neurological syndrome associated with clioquinol. Lancet. 1971;1:696–697. doi: 10.1016/S0140-6736(71)92699-7. [DOI] [PubMed] [Google Scholar]

Articles from Acta Veterinaria Scandinavica are provided here courtesy of BMC

RESOURCES